Introduction
TB-500 is a synthetic peptide fragment corresponding to amino acids 17–23 of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino acid protein found in virtually all nucleated cells in the human body. The active fragment sequence is Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr (often abbreviated to the core actin-binding motif LKKTETQ).
Thymosin Beta-4 is one of the most abundant intracellular proteins in mammalian cells and plays a central role in actin polymerisation, cell migration, and tissue repair. TB-500 has been studied as a research tool for investigating these pathways, with a substantial body of preclinical data across wound healing, cardiac repair, and neurological models.
All TB-500 products supplied by Alpha Peptides are intended strictly for in vitro and laboratory research use only and are not approved for human or veterinary administration.
Structure & Background
Thymosin Beta-4 was first isolated from thymus tissue in the 1960s and was initially studied in the context of immune function. Subsequent research revealed its central role in actin dynamics — Tβ4 is the primary actin-sequestering protein in cells, binding G-actin (globular actin) monomers and regulating their availability for polymerisation into F-actin (filamentous actin) networks.
The synthetic fragment TB-500 retains the actin-binding domain of the full Tβ4 protein and has been used extensively in preclinical research to study the downstream effects of Tβ4 signalling on tissue repair and regeneration. Its smaller size compared to the full protein confers practical advantages for research use, including improved stability and ease of synthesis.
Proposed Mechanisms of Action
- Actin sequestration: TB-500’s primary molecular function is binding G-actin monomers, preventing their incorporation into actin filaments. This regulation of actin dynamics is fundamental to cell motility, shape change, and division — all processes critical to tissue repair and wound healing.
- Cell migration promotion: By modulating actin dynamics, TB-500 promotes the migration of keratinocytes, endothelial cells, and fibroblasts — the key cell types involved in wound closure and tissue remodelling.
- Angiogenesis: TB-500 has been shown to promote angiogenesis through upregulation of VEGF and other pro-angiogenic factors, facilitating the formation of new blood vessels essential for tissue repair.
- Anti-inflammatory activity: Research has reported that Tβ4 and TB-500 modulate inflammatory signalling, including downregulation of NF-κB activity and reduction of pro-inflammatory cytokine expression, which may contribute to improved healing outcomes in inflammatory injury models.
- Stem cell recruitment: Some research has proposed that TB-500 promotes the recruitment and differentiation of progenitor cells to sites of injury, potentially contributing to tissue regeneration beyond simple wound closure.
Key Research Findings
Wound Healing
TB-500 and full-length Tβ4 have been extensively studied in wound healing models. Studies in rodents have demonstrated accelerated closure of full-thickness skin wounds, with improved re-epithelialisation, collagen deposition, and angiogenesis in treated animals. Corneal wound healing models have also shown significant acceleration of epithelial repair following Tβ4 treatment.
Cardiac Repair Research
One of the most significant areas of Tβ4/TB-500 research has been cardiac repair following myocardial infarction. Studies in rodent MI models have reported that Tβ4 treatment promotes cardiomyocyte survival, reduces infarct size, and stimulates the migration of epicardial progenitor cells into the damaged myocardium. These findings have generated considerable interest in Tβ4 as a research tool for studying endogenous cardiac repair mechanisms.
Tendon & Musculoskeletal Research
Preclinical studies have investigated TB-500 in tendon and muscle injury models, reporting improved healing outcomes and reduced fibrosis in treated animals. The proposed mechanisms include enhanced fibroblast migration, improved collagen organisation, and reduced inflammatory infiltration at injury sites.
Neurological Research
Research has explored Tβ4’s role in the central nervous system, where it is expressed in neurons and glial cells. Studies in models of spinal cord injury and stroke have reported neuroprotective and neuroregenerative effects, with proposed mechanisms including promotion of oligodendrocyte differentiation and axonal remyelination.
Hair Follicle Research
Tβ4 has been studied in the context of hair follicle biology, with research reporting effects on hair follicle stem cell activation and hair growth in animal models. This has generated interest in Tβ4 signalling pathways as research targets in hair biology.
TB-500 vs Full-Length Thymosin Beta-4
TB-500 is a fragment of Tβ4, not the full protein. While it retains the actin-binding domain and many of the biological activities of the full protein, researchers should be aware that some Tβ4 effects may require regions of the protein outside the TB-500 fragment. When designing research protocols, consider whether the full protein or the fragment is more appropriate for your specific research question.
Research Considerations
- The majority of TB-500 and Tβ4 research is preclinical. Human clinical data is limited, and extrapolation from animal models requires caution.
- TB-500 is a fragment of Tβ4 and may not fully recapitulate all activities of the complete protein.
- Tβ4 is endogenously expressed at high levels in platelets and is released at sites of injury — this physiological context is relevant when interpreting research findings.
- Refer to the Certificate of Analysis (COA) supplied with each batch for purity and sequence confirmation data.
Reconstitution & Storage
TB-500 should be reconstituted with bacteriostatic water to the required concentration. Store the reconstituted solution at 2–8°C and use within 28–30 days. For full guidance, refer to our Peptide Reconstitution Guide and Storage & Handling Guide.
Research Resources
Researchers can source TB-500 5mg (lyophilised) and TB-500 Pen 5mg from Alpha Peptides, each supplied with a full batch-specific COA. For related compounds studied in tissue repair and recovery research, explore our Recovery Research collection. TB-500 is frequently studied alongside BPC-157 — see our BPC-157 Research Overview for further context.
Disclaimer: All products sold by Alpha Peptides are intended strictly for in vitro research and laboratory use only. They are not approved for human or veterinary use, and this article does not constitute medical advice.
0 comments